913611-97-9,MFCD27987920
Catalog No.:AA00GR86

913611-97-9 | Brexpiprazole

Pack Size
Purity
Availability
Price(USD)
Quantity
  
10mg
≥98%
in stock  
$63.00   $44.00
- +
50mg
≥98%
in stock  
$186.00   $130.00
- +
250mg
95%
in stock  
$276.00   $193.00
- +
1g
95%
in stock  
$501.00   $351.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00GR86
Chemical Name:
Brexpiprazole
CAS Number:
913611-97-9
Molecular Formula:
C25H27N3O2S
Molecular Weight:
433.5658
MDL Number:
MFCD27987920
SMILES:
O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2
Properties
Computed Properties
 
Complexity:
636  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
31  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
7  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
4.7  

Literature

Title: The preclinical profile of brexpiprazole: what is its clinical relevance for the treatment of psychiatric disorders?

Journal: Expert review of neurotherapeutics 20151001

Title: Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?

Journal: International journal of clinical practice 20150901

Title: Brexpiprazole: First Global Approval.

Journal: Drugs 20150901

Title: Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator.

Journal: The Journal of pharmacology and experimental therapeutics 20140901

Title: Ishima T, et al. Potentiation of neurite outgrowth by brexpiprazole, a novel serotonin-dopamine activity modulator: a role for serotonin 5-HT1A and 5-HT2A receptors. Eur Neuropsychopharmacol. 2015 Apr;25(4):505-11.

Title: Yoshimi N, et al. Improvement of dizocilpine-induced social recognition deficits in mice by brexpiprazole, a novel serotonin-dopamine activity modulator. Eur Neuropsychopharmacol. 2015 Mar;25(3):356-64.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:913611-97-9 Molecular Formula|913611-97-9 MDL|913611-97-9 SMILES|913611-97-9 Brexpiprazole
Catalog No.: AA00GR86
913611-97-9,MFCD27987920
913611-97-9 | Brexpiprazole
Pack Size: 10mg
Purity: ≥98%
in stock
$63.00 $44.00
Pack Size: 50mg
Purity: ≥98%
in stock
$186.00 $130.00
Pack Size: 250mg
Purity: 95%
in stock
$276.00 $193.00
Pack Size: 1g
Purity: 95%
in stock
$501.00 $351.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00GR86
Chemical Name: Brexpiprazole
CAS Number: 913611-97-9
Molecular Formula: C25H27N3O2S
Molecular Weight: 433.5658
MDL Number: MFCD27987920
SMILES: O=c1ccc2c([nH]1)cc(cc2)OCCCCN1CCN(CC1)c1cccc2c1ccs2
Properties
Complexity: 636  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 31  
Hydrogen Bond Acceptor Count: 5  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 7  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 4.7  
Literature fold

Title: The preclinical profile of brexpiprazole: what is its clinical relevance for the treatment of psychiatric disorders?

Journal: Expert review of neurotherapeutics20151001

Title: Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?

Journal: International journal of clinical practice20150901

Title: Brexpiprazole: First Global Approval.

Journal: Drugs20150901

Title: Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator.

Journal: The Journal of pharmacology and experimental therapeutics20140901

Title: Ishima T, et al. Potentiation of neurite outgrowth by brexpiprazole, a novel serotonin-dopamine activity modulator: a role for serotonin 5-HT1A and 5-HT2A receptors. Eur Neuropsychopharmacol. 2015 Apr;25(4):505-11.

Title: Yoshimi N, et al. Improvement of dizocilpine-induced social recognition deficits in mice by brexpiprazole, a novel serotonin-dopamine activity modulator. Eur Neuropsychopharmacol. 2015 Mar;25(3):356-64.

Building Blocks More >
94-82-6
94-82-6
2,4-Dichlorophenoxybutyric acid
AA00GRIW | MFCD00002819
91291-66-6
91291-66-6
3-Amino-4,4,4-trifluorobutyric acid hydrochloride
AA00GRSM | MFCD00181951
886763-33-3
886763-33-3
1-[(1-Aminopropan-2-yl)oxy]-4-bromobenzene
AA00GRZ6 | MFCD07374148
934107-80-9
934107-80-9
1-Methanesulfonylpiperidin-3-amine
AA00GS6Q | MFCD06805749
883-20-5
883-20-5
9-Methylphenanthrene
AA00GSGS | MFCD00092279
876717-86-1
876717-86-1
[2-(2-Furyl)-2-morpholin-4-ylethyl]amine
AA00GSQ3 | MFCD07186445
871329-83-8
871329-83-8
4-Ethoxy-3-trifluoromethylphenylboronic acid
AA00GSW1 | MFCD07363789
864445-39-6
864445-39-6
1-pentyl-3-(2-methylphenylacetyl)indole
AA00GT8G | MFCD18382089
918904-39-9
918904-39-9
3-Bromo-5-isobutoxyphenylboronic acid
AA00GTBJ | MFCD17214245
88271-29-8
88271-29-8
2-(D-Gluco-pentylhydroxypentyl)-4(r)-1,3-thiazolidine-4-carboxylic acid
AA00GTJK | MFCD00186587
Submit
© 2017 AA BLOCKS, INC. All rights reserved.